ATE275379T1 - Zusammensetzungen und verfahren zur behandlung von alopezie - Google Patents

Zusammensetzungen und verfahren zur behandlung von alopezie

Info

Publication number: ATE275379T1
Authority: AT; Austria
Prior art keywords: applying; scalp; treating alopecia; compositions; methods
Prior art date: 1997-12-19

Application number

AT98964084T

Other languages

English (en)

Inventor

Morris A Mann

Original Assignee

Morris A Mann

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-19

Filing date

1998-12-18

Publication date

2004-09-15

1998-12-18 Application filed by Morris A Mann filed Critical Morris A Mann

2004-09-15 Application granted granted Critical

2004-09-15 Publication of ATE275379T1 publication Critical patent/ATE275379T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
201000004384 Alopecia Diseases 0.000 title abstract 2
231100000360 alopecia Toxicity 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
210000004761 scalp Anatomy 0.000 abstract 3
230000003660 hair regeneration Effects 0.000 abstract 2
102000011782 Keratins Human genes 0.000 abstract 1
108010076876 Keratins Proteins 0.000 abstract 1
UGPMCIBIHRSCBV-XNBOLLIBSA-N Thymosin beta 4 Chemical compound N([C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(C)=O UGPMCIBIHRSCBV-XNBOLLIBSA-N 0.000 abstract 1
101710202766 Thymosin beta-4 Proteins 0.000 abstract 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
230000003444 anaesthetic effect Effects 0.000 abstract 1
239000004202 carbamide Substances 0.000 abstract 1
239000003599 detergent Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Birds (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Dermatology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Cosmetics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT98964084T 1997-12-19 1998-12-18 Zusammensetzungen und verfahren zur behandlung von alopezie ATE275379T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/994,347 US6030948A (en)	1997-12-19	1997-12-19	Hair regeneration compositions for treatment of alopecia and methods of application related thereto
PCT/US1998/026955 WO1999032072A1 (en)	1997-12-19	1998-12-18	Compositions and methods for treatment of alopecia

Publications (1)

Publication Number	Publication Date
ATE275379T1 true ATE275379T1 (de)	2004-09-15

Family

ID=25540565

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98964084T ATE275379T1 (de)	1997-12-19	1998-12-18	Zusammensetzungen und verfahren zur behandlung von alopezie

Country Status (12)

Country	Link
US (1)	US6030948A (de)
EP (1)	EP1039874B1 (de)
JP (3)	JP2001526200A (de)
AT (1)	ATE275379T1 (de)
AU (1)	AU1928199A (de)
CA (1)	CA2315395C (de)
CY (1)	CY1105481T1 (de)
DE (1)	DE69826149T2 (de)
DK (1)	DK1039874T3 (de)
ES (1)	ES2232977T3 (de)
PT (1)	PT1039874E (de)
WO (1)	WO1999032072A1 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060100156A1 (en) *	2004-10-01	2006-05-11	Regenerx Biopharmaceuticals, Inc.	Cell nucleus-entering compositions
US20040067227A1 (en) *	2001-11-02	2004-04-08	Goldstein Allan L.	Inhibition or reversal of skin aging by actin-sequestering peptides
US20070015698A1 (en) *	1998-07-30	2007-01-18	United States Of America As Represented By The Secretary Of Health	Treatment of skin, and wound repair, with thymosin beta 4
US20070191275A1 (en) *	1998-07-30	2007-08-16	Regenerx Biopharmaceuticals, Inc.	Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
US20080096817A1 (en) *	1998-07-30	2008-04-24	Regenerx Biopharmaceuticals, Inc.	METHODS OF TREATING DISORDERS OF THE EYE AND SURROUNDING TISSUE WITH THYMOSIN BETA 4 (Tbeta4), ANALOGUES, ISOFORMS AND OTHER DERIVATIVES
AU766826B2 (en) *	1998-07-30	2003-10-23	Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The	Thymosin beta4 promotes wound repair
DE19957710A1 (de) *	1999-11-30	2001-05-31	Asat Ag Applied Science & Tech	Verwendung von Melatonin zur Behandlung der androgenetischen Alopezie
US6558656B2 (en) *	2000-04-20	2003-05-06	Morris Mann	Oral and topical compositions and methods related thereto in the treatment of acne
FR2813190A1 (fr) *	2000-08-22	2002-03-01	Oreal	Utilisation d'une sapogenine pour traiter les desordres lies a une suractivite de la 5-alpha reductase
US20040180809A1 (en) *	2000-10-16	2004-09-16	Mallinckrodt Inc.	Tissue-specific exogenous optical agents
US20070092450A1 (en) *	2000-10-16	2007-04-26	Mallinckrodt Inc.	Tissue-specific exogenous optical agents
US6716413B1 (en) *	2000-10-16	2004-04-06	Mallinckrodt, Inc.	Indole compounds as tissue-specific exogenous optical agents
US7244703B2 (en) *	2001-06-22	2007-07-17	Bentley Pharmaceuticals, Inc.	Pharmaceutical compositions and methods for peptide treatment
WO2003013245A1 (en) *	2001-08-07	2003-02-20	Wisconsin Alumni Research Foundation	Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
US20030049283A1 (en) *	2001-08-31	2003-03-13	Vandell Victor E.	Scalp desensitizing formulation
US7348352B2 (en) *	2001-10-23	2008-03-25	Bioresponse L.L.C.	Diindolylmethane for the treatment of HPV infection
TWI353849B (en) *	2002-01-25	2011-12-11	Us Gov Health & Human Serv	Methods and compositions for the promotion of hair
WO2003066572A1 (en) *	2002-02-07	2003-08-14	Wisconsin Alumni Research Foundation	Polyamine compounds and compositions for use in conjunction with cancer therapy
US6573301B1 (en) *	2002-04-23	2003-06-03	Bradley Pharmaceuticals, Inc.	Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use
US6821524B2 (en) *	2002-06-03	2004-11-23	Jan Marini Skin Research, Inc.	Cosmetic skin care compositions
DK1569724T3 (da) †	2002-10-30	2009-03-30	Asat Ag Applied Science & Tech	Formuleringer, der indeholder melatonin, gingko biloba og biotin
DK1562585T3 (da) *	2002-10-30	2011-03-14	Asat Ag Applied Science & Tech	Daglige melatonindoseringsenheder
US7622103B1 (en)	2003-03-27	2009-11-24	Cielo Jill M	Hair and scalp toxin remover composition and method of its making
FR2855753B1 (fr) *	2003-06-03	2007-09-14	Dermo Cosmologie Lab De	Composition a base de diosgenine applicable par voie topique
US20050084509A1 (en) *	2003-10-20	2005-04-21	Bernstein Eric F.	Use of citric acid and low concentrations of alpha-hydroxy acids for superficial skin treatment
CN101829319A (zh)	2003-12-08	2010-09-15	Cpex药品公司	用于胰岛素治疗的药用组合物及方法
US20050238672A1 (en) *	2004-04-27	2005-10-27	Nimni Marcel E	Antifungal drug delivery
US20060009430A1 (en) *	2004-07-01	2006-01-12	Kelly Gregory J	Composition for the prevention and treatment of the detrimental effects of dihydrotestosterone
US8349304B1 (en) *	2005-07-28	2013-01-08	Kerri Lynn Tate	Evaporative cooling composition
US20070048360A1 (en) *	2005-08-23	2007-03-01	R Carrara Dario N	Pharmaceutical compositions with melting point depressant agents and method of making same
GB0518558D0 (en) *	2005-09-12	2005-10-19	Givaudan Sa	Improvements in or related to organic compounds
WO2009068688A2 (en) *	2007-11-30	2009-06-04	Immundiagnostik Ag	Composition for treatment and prevention of hair loss and premature graying of hair
GB2461037A (en) *	2008-06-17	2009-12-23	Elias Bouras	A method of treating alopecia using a composition comprising a cardiac glycoside
CA2737025C (en) *	2008-09-27	2012-09-04	Jina Pharmaceuticals, Inc.	Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof
US20100120871A1 (en) *	2008-11-10	2010-05-13	Dawson Jr Thomas Larry	Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
US20100247693A1 (en) *	2009-03-24	2010-09-30	Marini Jan L	Cosmetic formulation to treat rosacea telangiectasia
FR2953722B1 (fr) *	2009-12-16	2012-03-09	Expanscience Lab	Composition comprenant au moins un sucre en c7 pour le traitement de l'alopecie, pour le traitement cosmetique des phaneres, et pour le soin des cheveux, cils ou ongles
JP2013514261A (ja) *	2009-12-18	2013-04-25	ロレアル	ケラチン繊維を処理する方法
JP5588167B2 (ja) *	2009-12-28	2014-09-10	ライオン株式会社	育毛養毛剤、毛周期変換剤および育毛養毛組成物
US8609604B2 (en)	2009-12-28	2013-12-17	N.V. Perricone Llc	Methods of improving the appearance of aging skin
US20110160144A1 (en) *	2009-12-28	2011-06-30	Perricone Nicholas V	Topical Acyl Glutathione Formulations
US8580742B2 (en)	2010-03-05	2013-11-12	N.V. Perricone Llc	Topical glutathione formulations for menopausal skin
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
WO2013190567A2 (en) *	2012-06-19	2013-12-27	Shome Debraj	Composition and method for an intradermal hair growth solution
JP5283775B1 (ja) *	2012-09-07	2013-09-04	佐藤製薬株式会社	発毛促進剤
FR2997846B1 (fr) *	2012-11-09	2023-10-20	Oreal	Composition comprenant un derive dicarbonyle et un acide, le procede de lissage des fibres keratiniques a partir de cette composition
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9808654B2 (en)	2013-02-11	2017-11-07	Jan Marini Skin Research	Post procedure skin care gel and methods of use thereof
EP3145489A1 (de)	2014-05-22	2017-03-29	TherapeuticsMD, Inc.	Natürliche kombinierte hormonersatzformulierungen und therapien
US11696883B2 (en)	2014-05-23	2023-07-11	Triple Hair Inc.	Compositions for reducing hair loss and/or increasing hair regrowth
WO2015176161A1 (en)	2014-05-23	2015-11-26	Triple Hair Inc.	Compositions for reducing hair loss and/or increasing hair regrowth
RU2016141135A (ru)	2014-07-29	2018-08-28	Терапьютиксмд, Инк.	Трансдермальный крем
ES2902842T3 (es)	2015-07-08	2022-03-30	Triple Hair Inc	Composición que comprende resveratrol y melatonina para reducir la caída y/o aumentar el crecimiento del cabello
DE102015111123A1 (de) *	2015-07-09	2017-01-12	Andreas Schulze	Kosmetische Pflege von ergrautem Haar
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
MX2018001843A (es) *	2015-08-13	2018-05-16	River Town Therapeutics Inc	Composiciones y metodos para tratar alopecia.
WO2017173044A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd Inc.	Steroid hormone compositions in medium chain oils
WO2017173071A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US9949939B2 (en)	2016-07-01	2018-04-24	Transdermal Biotechnology, Inc.	Systems and methods for treating vitiligo
ES2985673T3 (es) *	2017-07-11	2024-11-06	Shilpa Medicare Ltd	Composiciones tópicas de dutasterida
DE102019131415A1 (de) *	2019-11-21	2021-05-27	Lukas Karrer	Kosmetische Pflege von ergrautem Haar und Wiederrückführung von ergrautem Haar zur ursprünglichen Haarfarbe
CU24626B1 (es) *	2019-12-26	2022-11-07	Centro Nac De Biopreparados	Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations
EP3919044B1 (de) *	2020-06-04	2025-07-02	International Flavors & Fragrances Inc.	Zusammensetzung und verfahren zur verbesserung der duftintensität mit isopropylmyristat

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS60500619A (ja) *	1983-03-01	1985-05-02	トレンシユ，ル−ドルフ	毛髪処理剤および毛髪処理方法
JPS62252711A (ja) *	1986-04-24	1987-11-04	Hideharu Tamaki	養毛剤
US5068315A (en) *	1990-04-12	1991-11-26	University Of Dundee	Composition for the regulation of hair growth
DE19509354A1 (de) *	1994-12-08	1996-06-13	Klett Loch Lore M	Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
FR2741076B1 (fr) *	1995-11-15	1998-01-30	Rech De Pathologie Appliquee S	Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

1997
- 1997-12-19 US US08/994,347 patent/US6030948A/en not_active Expired - Fee Related
1998
- 1998-12-18 AU AU19281/99A patent/AU1928199A/en not_active Abandoned
- 1998-12-18 AT AT98964084T patent/ATE275379T1/de not_active IP Right Cessation
- 1998-12-18 CA CA002315395A patent/CA2315395C/en not_active Expired - Fee Related
- 1998-12-18 WO PCT/US1998/026955 patent/WO1999032072A1/en not_active Ceased
- 1998-12-18 DE DE69826149T patent/DE69826149T2/de not_active Expired - Lifetime
- 1998-12-18 EP EP98964084A patent/EP1039874B1/de not_active Expired - Lifetime
- 1998-12-18 JP JP2000525068A patent/JP2001526200A/ja not_active Withdrawn
- 1998-12-18 PT PT98964084T patent/PT1039874E/pt unknown
- 1998-12-18 ES ES98964084T patent/ES2232977T3/es not_active Expired - Lifetime
- 1998-12-18 DK DK98964084T patent/DK1039874T3/da active
2004
- 2004-12-08 CY CY20041101452T patent/CY1105481T1/el unknown
2007
- 2007-08-29 JP JP2007222548A patent/JP2007302705A/ja active Pending
2010
- 2010-05-14 JP JP2010112696A patent/JP2010168407A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
CA2315395C (en)	2008-03-18
DE69826149T2 (de)	2005-09-22
DE69826149D1 (de)	2004-10-14
JP2001526200A (ja)	2001-12-18
EP1039874B1 (de)	2004-09-08
PT1039874E (pt)	2005-02-28
CA2315395A1 (en)	1999-07-01
WO1999032072A1 (en)	1999-07-01
CY1105481T1 (el)	2010-04-28
ES2232977T3 (es)	2005-06-01
DK1039874T3 (da)	2005-01-24
US6030948A (en)	2000-02-29
JP2007302705A (ja)	2007-11-22
JP2010168407A (ja)	2010-08-05
EP1039874A1 (de)	2000-10-04
AU1928199A (en)	1999-07-12

Legal Events

Date

Code

Title

Description

2005-11-15

UEP

Publication of translation of european patent specification

Ref document number: 1039874

Country of ref document: EP

2007-10-15

EEIH

Change in the person of patent owner

2011-09-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE275379T1 (de)	2004-09-15	Zusammensetzungen und verfahren zur behandlung von alopezie
NO930368D0 (no)	1993-02-02	Sjampopreparat og suspensjonsmiddel for dette
FR2712286B1 (fr)	1995-12-22	Nouveaux N-mercaptoalkyl alcanediamines et leur utilisation.
AU617116B2 (en)	1991-11-21	Scalp treatment method
ATE214933T1 (de)	2002-04-15	Dermatologische zusammensetzungen, welche benzylneroxid und ein mittel zur verminderung von hautreizungen enthalten
DE69723476D1 (de)	2003-08-14	Mittel zur behandlung von haar
ATE209025T1 (de)	2001-12-15	Mittel zur behandlung von keratinmaterial, das zumindest ein silikongepfropftes polymer und mindestens ein höherkettiges amid enthält, sowie dessen verwendungen
LV12558A (lv)	2000-11-20	Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
ATA281885A (de)	1992-09-15	Faerbemittel, sowie faerbeverfahren fuer keratinfasern und insbesondere fuer humanhaare
DE3761286D1 (de)	1990-02-08	Haarkosmetische mittel.
ATA580880A (de)	1990-02-15	Mittel und verfahren zur behandlung von keratinfasern, insbesondere haaren
BR9714493A (pt)	2000-06-06	Composição cosmética, processo de tratamento cosmético das fibras queratìnicas e utilização de uma composição.
BR9501652A (pt)	1996-03-05	Usos de um antagonista de substancia P em uma composição cosmética processo de tratamento cosmético composição cosmética e uso da capsaicina
DE59308920D1 (de)	1998-10-01	Verfahren zur gewinnung von apfelwachs, durch diese verfahren erhältliches apfelwachs sowie apfelwachshaltige kosmetische mittel
DE69500062D1 (de)	1996-11-14	Set, Verfahren, Mittel und Zusammensetzung zur Färbung von Keratinfasern
DE69827633D1 (de)	2004-12-23	Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
ATE65388T1 (de)	1991-08-15	Kosmetisches mittel.
BR9501620A (pt)	1996-03-05	Composição para tratamento e proteção dos pélos queratinicos processo sem lavagem para tratamento e proteção dos lélos queratinicos e utilizações de composição
ATE202275T1 (de)	2001-07-15	Harnstoff enthaltende zusammensetzung und ihre kosmetische und dermatologische verwendung
ATE227969T1 (de)	2002-12-15	Verfahren und mittel zur dauerhaften verformung von keratinfasern
ATA904485A (de)	1994-05-15	Hautregenerierendes kosmetisches mittel und verfahren zu seiner herstellung
ATE321589T1 (de)	2006-04-15	Verwendung einer zubereitung und ein kosmetisches verfahren zur verminderung und vorbeugung von beissender der haut
FR2545720B1 (fr)	1986-09-19	Composition cosmetique pour le traitement des cheveux et de la peau, contenant des oxathiazinones
FR2760365B1 (fr)	2000-12-22	Composition pharmaceutique ou cosmetologique contenant au moins un retinoide, et methode de traitement cosmetique des modifications liees au vieillissement de la peau et/ou des phaneres
ATE260086T1 (de)	2004-03-15	Oxidationsfärbemittel für keratinfasern, das eine laccase enthält, und verfahren zur färbung mit diesem mittel